Search

everythinglearnresearchcommunity

for

Search:↓

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Severe acne in a young girl may indicate underlying hormonal issues.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

PCOS care in Singapore can be bettered by refining referral systems, standardizing diagnosis and treatment, enhancing complication screening, and offering educational resources for clinicians.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

High testosterone increases heart disease risk in women with PCOS.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Estrogens and progesterone are key in regulating melasma pigmentation.